Skip to content
ClinCalc Pro
Menu
Rheumatology A

ACR/EULAR SLE Classification Criteria 2019

2019 EULAR/ACR classification criteria for SLE: positive ANA (entry criterion), then weighted criteria in 7 clinical and 3 immunology domains — only the highest criterion in each domain counts. At least one clinical criterion and 10 or more points classify SLE. Count a criterion only if nothing explains it better than SLE; criteria need not occur at the same time.

Score interpretation

Not Classified — No Clinical Criterion -2

The criteria need at least one clinical criterion (constitutional, haematological, neuropsychiatric, mucocutaneous, serosal, musculoskeletal or renal); immunology alone does not classify SLE.

→ Follow up ANA-positive patients with SLE-specific antibodies; rheumatology opinion if clinical suspicion.

Not Classifiable — ANA Entry Criterion Not Met -1

Without ANA ≥ 1:80 at least once, the 2019 criteria cannot classify SLE.

→ Repeat ANA (HEp-2) if clinical suspicion; consider other connective tissue diseases; rheumatology opinion.

SLE Not Classified 0–9

Score <10: Does not meet 2019 ACR/EULAR classification for SLE

→ Consider other connective tissue diseases; follow up ANA-positive patients; rheumatology opinion if clinical suspicion

SLE Classified 10–51

Score ≥10: Meets 2019 ACR/EULAR criteria for SLE (requires positive ANA)

→ Rheumatology referral; baseline renal function, urinalysis, complement, anti-dsDNA; consider hydroxychloroquine; organise organ-specific investigations

Interpretation bands for the SLE Criteria 2019. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.